Renqingchangjue ameliorates MNNG-induced chronic atrophic gastritis by inhibiting the TNF/NF-κB/Caspase-3 axis

Key Points

• Chronic atrophic gastritis improvement linked to inhibition of the TNF/NF-κB/Caspase-3 axis.
• Inhibition observed with renqingchangjue treatment, suggesting a viable intervention.
• Inhibition of key inflammatory pathways contributes to the observed healing.
• Further exploration needed to confirm effects in larger cohorts or clinical trials.